eXceed Event: Virtual User and Applications Meeting

09:30 - 10:00 Intro and Proteomics Update
Torsten Müller, Ph.D., Business Development Manager - Proteomics (DACH), Bruker Daltonics, Germany

10:00 - 10:30 timsTOF Prosit improves the identification of non-tryptic peptides
Matthias Wilhelm, Ph.D., Professor, Computational Mass Spectrometry, Technical University Munich, Germany

10:30 - 11:00 A region-resolved proteomic map of the human brain enabled by high-throughput proteomics
Johanna Tueshaus, Ph.D., Postdoctoral researcher, Technical University Munich, Germany

11:00 - 11:10 Break

11:10 - 11:40 timsTOF mass spectrometry-based immunopeptidomics identification refines tumor antigen identification
Naomi Hönisch Gravel, Ph.D. Student, Peptide-based Immunotherapy, AG J. Walz, University and University Hospital Tübingen, Germany

11:40 - 12:10 µPhos: A scalable and sensitive platform for functional phosphoproteomics
Florian Meier, Ph.D., Junior Professor, Functional Proteome Analysis, Jena University Hospital, Germany

12:10 - 12:30 Meet the Experts
Lisa Abel, Field Application Scientist, Bruker Daltonics, Germany
Raphael Schuster, Ph.D., Field Application Scientist, Bruker Daltonics, Germany
Tobias Kroniger, Field Application Scientist, Bruker Daltonics, Germany 

09:30 - 10:00 Intro and Metabolomics/Lipidomics Update
Stefanie Wernisch, Ph.D., Business Development Manager Metabolomics/, Bruker Daltonics, Germany

10:00 - 10:30 Distinguishing ether-linked phospholipids by ion mobility coupled to mass spectrometry
Markus Keller, Ph.D., Principal Investigator, Medical University of Innsbruck, Institute of Human Genetics, Austria

10:30 - 11:00 Spatial metabolomics toward investigation of tissue heterogeneity and microenvironment
Laimdota Zizmare, Ph.D., Postdoctoral Researcher, The M3 Research Center for Microbiome, Metabolome and Malignancy, WSIC, University Hospital Tübingen, Germany

11:00 - 11:10 Break

11:10 - 11:40 SuperM – combining targeted and untargeted metabolomics into a single platform for target discovery and validation at scale
Marco Hennrich, Ph.D., Investigator, Cellzome GSK Heidelberg, Germany

11:40 - 12:10 Advancing lipidome’s quantitative coverage in pre-clinical and clinical samples with targeted and untargeted 4D- tims platforms
Laura Bindila, Ph.D., Head of Clinical Lipidomics Unit, University Medical Center Mainz, Institute of Physiological Chemistry, Germany

12:10 - 12:30 Meet the Experts
Viola Jeck, Ph.D., Application Scientist Metabolomics, Bruker Daltonics, Germany
Nikolas Kessler, Ph.D., Head of Metabolomics Software R&D, Bruker Daltonics, Germany
Sven Meyer, Ph.D., Applications Development Scientist, Bruker Daltonics, Germany

09:30 - 10:00 Intro and MALDI Imaging Update
Björn Wendik, Ph.D., Business Development Manager MALDI Imaging, Bruker Daltonics, Germany

10:00 - 10:30 Multimodal chemical imaging using spectroscopy and mass spectrometry
Uwe Karst, Ph.D., Chair of Analytical Chemistry, University of Münster, Institute of Inorganic and Analytical Chemistry, Germany

10:30 - 11:00 Simultaneous detection of over hundreds protein markers by MALDI-IHC: what have we learned so far
Mengze Zhang, Ph.D. student, University of Zurich, Department of Quantitative Biomedicine, Bodenmiller lab, Switzerland

11:00 - 11:10 Break

11:10 - 11:40 MALDI MSI – Applications in Pathology
Kristina Schwamborn, Ph.D., Head of  Mass Spectrometry Imaging (MSI) lab, Technical University Munich, Institute of Pathology, Germany

11:40 - 12:10 MALDI Imaging based spatial multi-omics for uncovering novel biomedical perspectives in rare cancers
Melanie Föll, Ph.D., Junior research group, University Medical Center Freiburg, Institute of Surgical Pathology, Germany

12:10 - 12:30 Meet the Experts
Andras Kiss, Ph.D., Field Application Support Engineer, Bruker Austria, Austria
Corinna Henkel, Ph.D., Application Specialist MALDI Imaging, Bruker Daltonics, Germany